Interfering with worms

Two systematic RNAi screens in worms provide the first large-scale reverse genetic analyses of a multicellular organism.

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the 16 November Nature, Fraser et al. and Gönczy et al. present the first large-scale reverse genetic analyses of a multicellular organism (Nature 2000, 408:325-330; Nature 2000, 408:331-336). Fraser et al. use RNA-mediated interference (RNAi to target 2,416 predicted genes on chromosome I of the worm Caenorhabditis elegans by feeding the worms with bacteria expressing double-stranded RNA. Of the analyzed genes, 13.9% show a phenotype, increasing the number of sequenced chromosome I genes with a known phenotype from 70 to 378. The identified genes include 90% of known embryonic lethal genes from chromosome I, but only 45% of genes with known post-embryonic phenotypes, with genes involved in nerve and sperm cell function apparently resistant to RNAi. The majority (60%) of the phenotypes were embryonic lethal, including many genes involved in basic metabolism. The largest class of post-embryonic phenotypes are in the uncoordinated (Unc) class, which generally relate to neuromuscular ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies